Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Mar;48(3):239-247.
doi: 10.1007/s00132-018-03659-5.

Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis : A prospective randomized controlled study

Yong Huang  1 , Xiaolu Liu  1 , Xinliang Xu  2 , Junbin Liu  3
Affiliations
Randomized Controlled Trial

Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis : A prospective randomized controlled study

Yong Huang et al. Orthopade. 2019 Mar.

Abstract

Background: Knee osteoarthritis (KOA) is a degenerative joint disease leading to pain and disability for which no curative treatment exists. Intra-articular (IA) therapies are part of this multimodal approach and are approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA). Platelet-rich plasma (PRP), hyaluronic acid (HA), and corticosteroids (CS) have been increasingly used in recent years to treat KOA.

Purpose: To determine whether IA-PRP was superior to IA-HA or IA-CS administration routes in these patients.

Material and methods: In this trial the patients were randomized to IA-HA (2 ml/week, for 3 weeks), IA-CS (1 ml) or IA-PRP (3 times, 4 ml, every 3 weeks) groups. The outcome was assessed using the Western Ontario and McMaster Universities (WOMAC) score prior to the first injection and then at 3, 6, 9 and 12 months. Pain was evaluated by a visual analogue scale (VAS) prior to treatment and after 12 months.

Results: In this study 120 patients were randomized into 3 groups. There was a significant improvement in all scores (WOMAC, VAS) in each group compared to the pretreatment values (P < 0.05). The mean WOMAC scores for the IA-HA group from pretreatment to 3, 6, 9, and 12 months were 47.23 ± 5.37, 25.02 ± 4.98, 26.38 ± 5.20, 27.86 ± 4.34, and 30.64 ± 8.36, respectively. Similar improvements were noted in the IA-CS and IA-PRP groups. There were no significant differences in the WOMAC scores between the 3 groups 3 months after treatment (P > 0.05) but IA-PRP showed significantly lower scores 6, 9 and 12 months after treatment (P < 0.05).

Conclusion: Intra-articular PRP injections into the knee for symptomatic early stages of KOA are a valid treatment option. The clinical efficacy of IA-PRP is comparable to that of the IA-HA and IA-CS forms after 3 months and the long-term efficacy of IA PRP is superior to IA-HA and IA-CS.

Keywords: Assessment, outcomes; Degenerative joint disease; Multimodal treatment; Viscosupplementation; Visual analog scale.

PubMed Disclaimer

References

    1. Zhonghua Yi Xue Za Zhi. 2003 Jul 25;83(14):1206-9 - PubMed
    1. Ann Rheum Dis. 1957 Dec;16(4):494-502 - PubMed
    1. J Oral Maxillofac Surg. 2004 Apr;62(4):489-96 - PubMed
    1. Tissue Eng Part B Rev. 2008 Sep;14(3):249-58 - PubMed
    1. Trends Biotechnol. 2009 Mar;27(3):158-67 - PubMed

Publication types